Literature DB >> 26110355

Ocular Tuberculosis--A Clinical Conundrum.

Cecilia Lee1,2, Rupesh Agrawal1,3, Carlos Pavesio1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2015        PMID： 26110355      PMCID： PMC4760910          DOI： 10.3109/09273948.2014.985387

Source DB:  PubMed          Journal:  Ocul Immunol Inflamm        ISSN： 0927-3948            Impact factor:   3.070


× No keyword cloud information.
  49 in total

Review 1.  Infectious causes of uveitis in the developing world.

Authors:  S R Rathinam; E T Cunningham
Journal:  Int Ophthalmol Clin       Date:  2000

2.  Disseminated tuberculosis, pulmonary aspergillosis and cutaneous herpes simplex infection in a patient with infliximab and methotrexate.

Authors:  J M van der Klooster; R J Bosman; H M Oudemans-van Straaten; J I van der Spoel; J P J Wester; D F Zandstra
Journal:  Intensive Care Med       Date:  2003-11-05       Impact factor: 17.440

3.  Interferon-gamma release assays in the diagnosis of tuberculous uveitis.

Authors:  Thomas A Albini; Petros C Karakousis; Narsing A Rao
Journal:  Am J Ophthalmol       Date:  2008-10       Impact factor: 5.258

4.  Pitfalls in the management of TB-associated uveitis.

Authors:  S Basu; T Das
Journal:  Eye (Lond)       Date:  2010-08-13       Impact factor: 3.775

Review 5.  A systematic review of rapid diagnostic tests for the detection of tuberculosis infection.

Authors:  J Dinnes; J Deeks; H Kunst; A Gibson; E Cummins; N Waugh; F Drobniewski; A Lalvani
Journal:  Health Technol Assess       Date:  2007-01       Impact factor: 4.014

6.  Tuberculosis after conversion from azathioprine to mycophenolate mofetil in a long-term renal transplant recipient.

Authors:  L Mercadal; V Foltz; C Isnard-Bagnis; S Ourahma; G Deray
Journal:  Transplant Proc       Date:  2005-12       Impact factor: 1.066

7.  Indirect supportive evidence for diagnosis of tuberculosis-related uveitis: from the tuberculin skin test to the new interferon gamma release assays.

Authors:  Víctor Llorenç; Julian González-Martin; Johannes Keller; Amanda Rey; Laura Pelegrín; Marina Mesquida; Alfredo Adán
Journal:  Acta Ophthalmol       Date:  2012-10-08       Impact factor: 3.761

8.  Diagnosis of tuberculous uveitis: clinical application of an interferon-gamma release assay.

Authors:  Marcus Ang; Hla Myint Htoon; Soon-Phaik Chee
Journal:  Ophthalmology       Date:  2009-07       Impact factor: 12.079

9.  Impact of blood volume, tube shaking, and incubation time on reproducibility of QuantiFERON-TB gold in-tube assay.

Authors:  Rajiv L Gaur; Madhukar Pai; Niaz Banaei
Journal:  J Clin Microbiol       Date:  2013-08-21       Impact factor: 5.948

10.  Factors influencing polymerase chain reaction outcomes in patients with clinically suspected ocular tuberculosis.

Authors:  Praveen Kumar Balne; Rohit Ramesh Modi; Nuzhat Choudhury; Neha Mohan; Manas Ranjan Barik; Tapas Ranjan Padhi; Savitri Sharma; Satya Ranjan Panigrahi; Soumyava Basu
Journal:  J Ophthalmic Inflamm Infect       Date:  2014-03-25
View more
  12 in total

Review 1.  Anti-tubercular therapy for intraocular tuberculosis: A systematic review and meta-analysis.

Authors:  Ae Ra Kee; Julio J Gonzalez-Lopez; Aws Al-Hity; Bhaskar Gupta; Cecilia S Lee; Dinesh Visva Gunasekeran; Nirmal Jayabalan; Robert Grant; Onn Min Kon; Vishali Gupta; Mark Westcott; Carlos Pavesio; Rupesh Agrawal
Journal:  Surv Ophthalmol       Date:  2016-03-10       Impact factor: 6.048

2.  Early treatment of tuberculous uveitis improves visual outcome: a 10-year cohort study.

Authors:  Luis Anibarro; Eliana Cortés; Ana Chouza; Alberto Parafita-Fernández; Juan Carlos García; Alberto Pena; Carlos Fernández-Cid; África González-Fernández
Journal:  Infection       Date:  2018-06-04       Impact factor: 3.553

3.  The Association between QuantiFERON-TB Gold Test and Clinical Manifestations of Uveitis in the United States.

Authors:  Mehmet Yakin; Natasha Kesav; Shuk Kei Cheng; Sonny Caplash; Sapna Gangaputra; H Nida Sen
Journal:  Am J Ophthalmol       Date:  2021-05-02       Impact factor: 5.488

4.  Implementation of the LOOP pathway-a framework for the management of ocular tuberculosis across the United Kingdom?

Authors:  Huzaifa Malick; Martin Wiselka; Periyasamy Kumar; Bharat Kapoor
Journal:  Eye (Lond)       Date:  2021-01-14       Impact factor: 4.456

5.  Diminished TLR2-TLR9 mediated CD4+ T cell responses are associated with increased inflammation in intraocular tuberculosis.

Authors:  Ravi Kumar Sharma; Jyoti Sharma; Zafar K Khan; Ajinkya Pattekar; Vishali Gupta; Reema Bansal; Kusum Sharma; Ashutosh Nath Aggarwal; Amod Gupta; Naresh Sachdeva
Journal:  Sci Rep       Date:  2018-09-14       Impact factor: 4.379

6.  Clinical Profile and Treatment Response of Patients with Ocular Inflammation due to Presumed Ocular Tuberculosis: A Retrospective Study

Authors:  Suma Elangovan; Senthamarai Govindarajan; Lakshmi Mayilvakanam; Nithya Gunasekaran
Journal:  Turk J Ophthalmol       Date:  2019-09-03

Review 7.  Ocular tuberculosis: Where are we today?

Authors:  Ilaria Testi; Rupesh Agrawal; Salil Mehta; Soumvaya Basu; Quan Nguyen; Carlos Pavesio; Vishali Gupta
Journal:  Indian J Ophthalmol       Date:  2020-09       Impact factor: 1.848

8.  Intraocular Tuberculosis: A Challenging Case Mimicking Wet Age-Related Macular Degeneration.

Authors:  Emanuela Interlandi; Francesco Pellegrini; Carlos Pavesio; Marco De Luca; Rocco De Marco; Alessandro Papayannis; Erika Mandarà; Alessandra Cuna; Daniele Cirone; Cristina Ciabattoni; Tatiana Liberali; Antonio Zappacosta; Loredana Latanza
Journal:  Case Rep Ophthalmol       Date:  2021-06-11

9.  Transcriptional Profile of Mycobacterium tuberculosis in an in vitro Model of Intraocular Tuberculosis.

Authors:  Sudhanshu Abhishek; Uma Nahar Saikia; Amod Gupta; Reema Bansal; Vishali Gupta; Nirbhai Singh; Suman Laal; Indu Verma
Journal:  Front Cell Infect Microbiol       Date:  2018-10-02       Impact factor: 5.293

10.  A case report of ocular tuberculosis in a patient with membranous nephropathy.

Authors:  Xiaofang Yin; Haibo Ge; Ruifen Miao
Journal:  Medicine (Baltimore)       Date:  2019-01       Impact factor: 1.889
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.